Search research articles
Contact Us
Filters
Showing results (1-10 of 28) with videos related to
Page
of 3
Sort By:
Plos Medicine
|
April 9, 2026
Spatial omics and AI for clinically actionable cancer biomarkers
Nic G Reitsam
NPJ Precision Oncology
|
July 31, 2024
The SARIFA biomarker in the context of basic research of lipid-driven cancers
Bruno Märkl, Nic G Reitsam, Przemyslaw Grochowski, et al.
Clinical Nuclear Medicine
|
June 5, 2025
[ 18 F]FDG PET/CT in Primary Angiosarcoma of the Thyroid
Lisa Glantschnig, Nic G Reitsam, Timm Kleffel, et al.
Pathologie (Heidelberg, Germany)
|
October 4, 2024
[SARIFA-a new multi-entity biomarker]
Bianca Grosser, Nic G Reitsam, Przmyslaw Grochowski, et al.
Clinical Nuclear Medicine
|
January 23, 2025
Intense FAP Expression of Ovarian Metastatic Breast Cancer Detected by [ 68 Ga]RTX-1363 PET/CT
Lisa Glantschnig, Nic G Reitsam, Malte Kircher Md, et al.
The Journal of Pathology. Clinical Research
|
April 16, 2026
HISTAI: a valuable dataset with a valuable lesson
Katherine J Hewitt, Nic G Reitsam, Sebastian Foersch, et al.
BMC Cancer
|
June 26, 2024
The Concept of Stroma AReactive Invasion Front Areas (SARIFA) as a new prognostic biomarker for lipid-driven cancers holds true in pancreatic ductal adenocarcinoma
Przemyslaw Grochowski, Bianca Grosser, Florian Sommer, et al.
Cancer Gene Therapy
|
November 22, 2023
Novel biomarker SARIFA in colorectal cancer: highly prognostic, not genetically driven and histologic indicator of a distinct tumor biology
Nic G Reitsam, Veselin Grozdanov, Chiara M L Löffler, et al.
Journal of Pathology Informatics
|
June 12, 2026
SCRIPT: Stratified clinical risk prediction from pathology reports using large language models
Chiara M L Loeffler, Nic G Reitsam, Fabian Wolf, et al.
BMC Cancer
|
January 12, 2024
SARIFA as a new histopathological biomarker is associated with adverse clinicopathological characteristics, tumor-promoting fatty-acid metabolism, and might predict a metastatic pattern in pT3a prostate cancer
Johanna S Enke, Matthias Groß, Bianca Grosser, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 28) with videos related to
Sort By:
Page
of 3
Plos Medicine
|
April 9, 2026
Spatial omics and AI for clinically actionable cancer biomarkers
Nic G Reitsam
NPJ Precision Oncology
|
July 31, 2024
The SARIFA biomarker in the context of basic research of lipid-driven cancers
Bruno Märkl, Nic G Reitsam, Przemyslaw Grochowski, et al.
Clinical Nuclear Medicine
|
June 5, 2025
[ 18 F]FDG PET/CT in Primary Angiosarcoma of the Thyroid
Lisa Glantschnig, Nic G Reitsam, Timm Kleffel, et al.
Pathologie (Heidelberg, Germany)
|
October 4, 2024
[SARIFA-a new multi-entity biomarker]
Bianca Grosser, Nic G Reitsam, Przmyslaw Grochowski, et al.
Clinical Nuclear Medicine
|
January 23, 2025
Intense FAP Expression of Ovarian Metastatic Breast Cancer Detected by [ 68 Ga]RTX-1363 PET/CT
Lisa Glantschnig, Nic G Reitsam, Malte Kircher Md, et al.
The Journal of Pathology. Clinical Research
|
April 16, 2026
HISTAI: a valuable dataset with a valuable lesson
Katherine J Hewitt, Nic G Reitsam, Sebastian Foersch, et al.
BMC Cancer
|
June 26, 2024
The Concept of Stroma AReactive Invasion Front Areas (SARIFA) as a new prognostic biomarker for lipid-driven cancers holds true in pancreatic ductal adenocarcinoma
Przemyslaw Grochowski, Bianca Grosser, Florian Sommer, et al.
Cancer Gene Therapy
|
November 22, 2023
Novel biomarker SARIFA in colorectal cancer: highly prognostic, not genetically driven and histologic indicator of a distinct tumor biology
Nic G Reitsam, Veselin Grozdanov, Chiara M L Löffler, et al.
Journal of Pathology Informatics
|
June 12, 2026
SCRIPT: Stratified clinical risk prediction from pathology reports using large language models
Chiara M L Loeffler, Nic G Reitsam, Fabian Wolf, et al.
BMC Cancer
|
January 12, 2024
SARIFA as a new histopathological biomarker is associated with adverse clinicopathological characteristics, tumor-promoting fatty-acid metabolism, and might predict a metastatic pattern in pT3a prostate cancer
Johanna S Enke, Matthias Groß, Bianca Grosser, et al.
Page
of 3